Cargando…

Dyspnoea-12: a translation and linguistic validation study in a Swedish setting

BACKGROUND: Dyspnoea consists of multiple dimensions including the intensity, unpleasantness, sensory qualities and emotional responses which may differ between patient groups, settings and in relation to treatment. The Dyspnoea-12 is a validated and convenient instrument for multidimensional measur...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundh, Josefin, Ekström, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734213/
https://www.ncbi.nlm.nih.gov/pubmed/28592574
http://dx.doi.org/10.1136/bmjopen-2016-014490
_version_ 1783287018166419456
author Sundh, Josefin
Ekström, Magnus
author_facet Sundh, Josefin
Ekström, Magnus
author_sort Sundh, Josefin
collection PubMed
description BACKGROUND: Dyspnoea consists of multiple dimensions including the intensity, unpleasantness, sensory qualities and emotional responses which may differ between patient groups, settings and in relation to treatment. The Dyspnoea-12 is a validated and convenient instrument for multidimensional measurement in English. We aimed to take forward a Swedish version of the Dyspnoea-12. METHODS: The linguistic validation of the Dyspnoea-12 was performed (Mapi Language Services, Lyon, France). The standardised procedure involved forward and backward translations by three independent certified translators and revisions after feedback from an in-country linguistic consultant, the developerand three native physicians. The understanding and convenience of the translated version was evaluated using qualitative in-depth interviews with five patients with dyspnoea. RESULTS: A Swedish version of the Dyspnoea-12 was elaborated and evaluated carefully according to international guidelines. The Swedish version, ‘Dyspné−12’, has the same layout as the original version, including 12 items distributed on seven physical and five affective items. The Dyspnoea-12 is copyrighted by the developer but can be used free of charge after permission for not industry-funded research. CONCLUSION: A Swedish version of the Dyspnoea-12 is now available for clinical validation and multidimensional measurement across diseases and settings with the aim of improved evaluation and management of dyspnoea.
format Online
Article
Text
id pubmed-5734213
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57342132017-12-20 Dyspnoea-12: a translation and linguistic validation study in a Swedish setting Sundh, Josefin Ekström, Magnus BMJ Open Respiratory Medicine BACKGROUND: Dyspnoea consists of multiple dimensions including the intensity, unpleasantness, sensory qualities and emotional responses which may differ between patient groups, settings and in relation to treatment. The Dyspnoea-12 is a validated and convenient instrument for multidimensional measurement in English. We aimed to take forward a Swedish version of the Dyspnoea-12. METHODS: The linguistic validation of the Dyspnoea-12 was performed (Mapi Language Services, Lyon, France). The standardised procedure involved forward and backward translations by three independent certified translators and revisions after feedback from an in-country linguistic consultant, the developerand three native physicians. The understanding and convenience of the translated version was evaluated using qualitative in-depth interviews with five patients with dyspnoea. RESULTS: A Swedish version of the Dyspnoea-12 was elaborated and evaluated carefully according to international guidelines. The Swedish version, ‘Dyspné−12’, has the same layout as the original version, including 12 items distributed on seven physical and five affective items. The Dyspnoea-12 is copyrighted by the developer but can be used free of charge after permission for not industry-funded research. CONCLUSION: A Swedish version of the Dyspnoea-12 is now available for clinical validation and multidimensional measurement across diseases and settings with the aim of improved evaluation and management of dyspnoea. BMJ Publishing Group 2017-06-06 /pmc/articles/PMC5734213/ /pubmed/28592574 http://dx.doi.org/10.1136/bmjopen-2016-014490 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Respiratory Medicine
Sundh, Josefin
Ekström, Magnus
Dyspnoea-12: a translation and linguistic validation study in a Swedish setting
title Dyspnoea-12: a translation and linguistic validation study in a Swedish setting
title_full Dyspnoea-12: a translation and linguistic validation study in a Swedish setting
title_fullStr Dyspnoea-12: a translation and linguistic validation study in a Swedish setting
title_full_unstemmed Dyspnoea-12: a translation and linguistic validation study in a Swedish setting
title_short Dyspnoea-12: a translation and linguistic validation study in a Swedish setting
title_sort dyspnoea-12: a translation and linguistic validation study in a swedish setting
topic Respiratory Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734213/
https://www.ncbi.nlm.nih.gov/pubmed/28592574
http://dx.doi.org/10.1136/bmjopen-2016-014490
work_keys_str_mv AT sundhjosefin dyspnoea12atranslationandlinguisticvalidationstudyinaswedishsetting
AT ekstrommagnus dyspnoea12atranslationandlinguisticvalidationstudyinaswedishsetting